Eucerin DermoPure Triple Effect Concentrated Cleansing Gel 400ml

A clinically tested cleanser with 2% Salicylic Acid. Developed to reduce imperfections, post-acne marks and shine.

A clinically tested cleanser with 2% Salicylic Acid. Developed to reduce imperfections, post-acne marks and shine

Cleansing gel with 2% Salicylic Acid, for oily, acne-prone skin

Acne is a common reality in many people's lives. It affects up to 95% of adolescents and 40% of adults*. Many people experience post-acne marks (post-inflammatory hyperpigmentation or PIH) long after the acute acne has disappeared. After fighting imperfections, they still have to combat post-acne marks that can persist for several years or even a decade**, with the sun contributing to their worsening.
Around 87% of people have post-acne marks. Men and women are equally susceptible, and all skin types can experience post-acne marks, although they are more prevalent in darker skin tones***.
Eucerin DermoPure Triple Effect Concentrated Cleansing Gel with 2% Salicylic Acid helps to finally overcome blemishes and post-acne marks with 3 key factors:

Anti-acne: 2% antibacterial Salicylic Acid to reduce impurities and unclog pores.
Anti-blemish: Exfoliating complex of AHA/BHA/PHA acids to remove dead skin cells and reduce marks (post-inflammatory hyperpigmentation).
Anti-shine: Deeply cleanses to remove excess sebum, dirt and makeup.

For an immediate feeling of clean, fresh skin and a visible reduction in post-acne marks over time.
96% confirm that the product has an anti-acne, anti-stain and anti-shine effect. ****
The Triple Effect Concentrated Cleansing Gel provides the ideal routine when used in conjunction with the DermoPure Triple Effect Serum (with patented Thiamidol) and DermoPure Protective Fluid SPF 30.
* Zouboulis, C. C., Hautarzt. 2014; 65(8):733–750.
** Abad-Casintahan, F. et al., “Frequency and Characteristics of Acne-Related Post-Inflammatory Hyperpigmentation.” J Dermatol. 2016; 43:826–828.
*** Elbuluk N, Grimes P, Chien A et al. The pathogenesis and management of acne-induced post-inflammatory hyperpigmentation. Am J Clin Dermatol 2021; 22:829–36.
**** Beiersdorf AG, PiU, Thailand, September/October 2022, carried out with 119 people suffering from post-acne marks aged between 12 and 40 years.